Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bartee

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Virology|October 31, 2008
The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblastsEric Bartee, Mohamed R Mohamed, M Cecilia Lopez, et al.
Journal of Virology|December 15, 2004
The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factoriesBianca T Hovey Nerenberg, John Taylor, Eric Bartee, et al.
Plos One|December 15, 2010
Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomesEric Bartee, Craig A Eyster, Kasinath Viswanathan, et al.
Oncolytic Virotherapy|December 13, 2018
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiformeChase Burton, Arabinda Das, Daniel McDonald, et al.
Virology|March 26, 2010
Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cellsNancy Y Villa, Eric Bartee, Mohamed R Mohamed, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2022
The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid TumorsCody C Gowan, Mee Y Bartee, Erica Flores, et al.
Leukemia Research|February 21, 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitroGerard J Madlambayan, Eric Bartee, Manbok Kim, et al.
Journal of Virology|December 28, 2002
The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4Mandana Mansouri, Eric Bartee, Kristine Gouveia, et al.
Journal of Virology|January 5, 2023
High Levels of Extracellular Potassium Can Delay Myxoma Virus Replication by Preventing Release of Virions from the EndosomesHeather D Curtsinger, Xianyi Zeng, Zaira Mather, et al.
Oncoimmunology|December 3, 2024
Regional immune mechanisms enhance efficacy of an autologous cellular cancer vaccine with intraperitoneal administrationBen Marwedel, Lorél Y Medina, Henning De May, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Virology|October 31, 2008
The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblastsEric Bartee, Mohamed R Mohamed, M Cecilia Lopez, et al.
Journal of Virology|December 15, 2004
The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factoriesBianca T Hovey Nerenberg, John Taylor, Eric Bartee, et al.
Plos One|December 15, 2010
Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomesEric Bartee, Craig A Eyster, Kasinath Viswanathan, et al.
Oncolytic Virotherapy|December 13, 2018
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiformeChase Burton, Arabinda Das, Daniel McDonald, et al.
Virology|March 26, 2010
Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cellsNancy Y Villa, Eric Bartee, Mohamed R Mohamed, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2022
The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid TumorsCody C Gowan, Mee Y Bartee, Erica Flores, et al.
Leukemia Research|February 21, 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitroGerard J Madlambayan, Eric Bartee, Manbok Kim, et al.
Journal of Virology|December 28, 2002
The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4Mandana Mansouri, Eric Bartee, Kristine Gouveia, et al.
Journal of Virology|January 5, 2023
High Levels of Extracellular Potassium Can Delay Myxoma Virus Replication by Preventing Release of Virions from the EndosomesHeather D Curtsinger, Xianyi Zeng, Zaira Mather, et al.
Oncoimmunology|December 3, 2024
Regional immune mechanisms enhance efficacy of an autologous cellular cancer vaccine with intraperitoneal administrationBen Marwedel, Lorél Y Medina, Henning De May, et al.
Pageof 5